Latest Headlines

  1. Becton Dickinson Diversifies Via $24 Billion C.R. Bard Acquisition
    4/25/2017

    Becton Dickinson (BD) is paying $24 billion in cash and stock to acquire C. R. Bard to move beyond diabetes care and into peripheral vascular disease, urology, hernia, and cancer treatments, as well as to round out its market-leading medication management portfolio.

  2. GE Beats Q1 Forecasts On Strength Of Double-Digit Growth In Healthcare Equipment
    4/25/2017

    GE continues to report “solid” performance for its healthcare sector, despite what CEO Jeffrey Immelt called “slow growth in a volatile environment” and challenges in other segments

  3. Danaher CEO Expects Acquisitions, R&D To Fuel Long-Term Growth
    4/24/2017

    Danaher Corporation's recent acquisitions, reinvestments, and the Chinese market will continue to help drive long-term growth, according to the company's CEO, Thomas P. Joyce, Jr.

  4. Smaller, Gentler Brain Electrodes Worth Their Weight In Gold…And Graphene
    4/24/2017

    Scientists in South Korea are mining the biomedical potential of both gold and graphene to design a more flexible brain-machine interface (BMI) that can transmit clearer signals while causing minimal damage to brain tissue, said researchers. 

  5. Medtronic Announces Updated Neurosurgery Stealthstation
    4/24/2017

    Medtronic plc. recently launched its new StealthStation technology at the American Academy of Neurological Surgeons (AANS) annual conference in Los Angeles. StealthStation technology has been a mainstay in neurosurgery suites for the past 25 years, being used in more than 2.25 million procedures.  

  6. Siemens Healthineers Boosts Population Health Portfolio With Medicalis Buy
    4/21/2017

    Siemens is looking to expand its portfolio of population health management (PHM) solutions with the acquisition of San Francisco-based tech firm Medicalis, which specializes in tools that maximize efficiency in clinical decisions, imaging workflow, and scheduling management.

  7. Abbott CEO Confident In Closing Alere Deal, Solving St. Jude Facility Issue
    4/21/2017

    Abbott CEO Miles White is optimistic that the company will overcome remaining hurdles to complete the purchase of Alere by the end of the third quarter, and that it will clear up manufacturing quality issues involving a plant acquired from St. Jude Medical.

  8. FDA Clears Cardiac Insight’s Wearable ECG Sensor
    4/20/2017

    Cardiac Insight, a U.S. developer of body worn sensing devices and computational software, announced recently, the FDA has cleared the company’s wearable electrocardiogram (ECG) sensor, CARDEA SOLO. The device offers physicians immediate access to improved reporting and analysis of heartbeat-to-heartbeat data.

  9. FDA Clears First Cooled RF Treatment For OA Knee Pain
    4/20/2017

    American Society of Interventional Pain Physicians Annual Meeting, Booth #407 -- Halyard Health (NYSE: HYH), a medical technology company focused on eliminating pain, speeding recovery and preventing infection, today announced the U.S. Food and Drug Administration (FDA) has cleared for marketing its COOLIEF* Cooled Radiofrequency (Cooled RF) thermal treatment for the relief of chronic moderate to severe knee pain caused by osteoarthritis (OA).

  10. Depuy Synthes Acquires 3D Printing Tech To Treat Bone Defects
    4/20/2017

    DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries.